Announcement on Resignation of Vice Chairman

Earlier from Guangzhou Baiyunshan Pharmaceutical

• Announcement on Progress in Subsidiary’s Acquisition of 100% Equity of Zhejiang Pharmaceutical Industry Corp., Ltd.Mar 4
• Announcement on Progress in Guangzhou Guangyao Phase II Fund Equity Investment Partnership (Limited Partnership) Acquiring an 11.04% Equity Interest in Nanjing Pharmaceutical Company LimitedFeb 28
• Announcement on Partial Drugs Being Selected for National Procurement Continuation After the Expiry of AgreementFeb 12
• Announcement on Branch Obtaining Drug Supplementary Application ApprovalFeb 11
• Announcement on Subsidiary's Drug Passing Generic Consistency EvaluationFeb 7

Later from Guangzhou Baiyunshan Pharmaceutical

• Announcement on Subsidiary Obtaining Notice of Approval for Drug Clinical TrialsMar 17
• Special Report on Deposit, Management and Actual Use of Raised Funds in 2025Mar 21
• Announcement on Branch Receiving Pharmaceutical Registration Certificate in MacauApr 2
• Announcement on Recognition of Subsidiary as High-tech EnterpriseApr 16
• Announcement on Resolutions of the 34th Meeting of the 9th Board of DirectorsApr 28